Patents by Inventor Sabine Gratzer

Sabine Gratzer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9782411
    Abstract: {4-[5-(3-chloro-phenoxy)-oxazolo[5,4-d]pyrimidin-2-yl]-2,6-dimethyl-phenoxy}-acetic acid or a pharmaceutically acceptable salt thereof for use in the prevention or treatment of AKI (acute kidney injury). Medicament and pharmaceutical composition thereof.
    Type: Grant
    Filed: October 15, 2014
    Date of Patent: October 10, 2017
    Assignee: SANOFI
    Inventors: Véronique Briand, Sabine Gratzer, Thomas Huebschle, Philip Janiak, Dieter Kadereit, Ashfaq Parkar, Bruno Poirier, Matthias Schaefer, Paulus Wohlfart
  • Publication number: 20160235756
    Abstract: {4-[5-(3-chloro-phenoxy)-oxazolo[5,4-d]pyrimidin-2-yl]-2,6-dimethyl-phenoxy}-acetic acid or a pharmaceutically acceptable salt thereof for use in the prevention or treatment of AKI (acute kidney injury). Medicament and pharmaceutical composition thereof.
    Type: Application
    Filed: October 15, 2014
    Publication date: August 18, 2016
    Applicant: Sanofi
    Inventors: Véronique BRIAND, Sabine GRATZER, Thomas HUEBSCHLE, Philip JANIAK, Dieter KADEREIT, Ashfaq PARKAR, Bruno POIRIER, Matthias SCHAEFER, Paulus WOHLFART
  • Patent number: 8642259
    Abstract: The present invention relates to methods for identifying substances capable of influencing the activity of a target molecule affecting cellular proliferation.
    Type: Grant
    Filed: July 23, 2003
    Date of Patent: February 4, 2014
    Assignee: Sanofi-Aventis Deutschland GmbH
    Inventors: Sabine Gratzer, Meltsje De Hoop, Bernhard Mai
  • Publication number: 20080166748
    Abstract: The present invention relates to a method of identifying protein Constitutively Active Mutants (CAMs) and the use thereof.
    Type: Application
    Filed: March 9, 2007
    Publication date: July 10, 2008
    Applicant: Sanofi-Aventis Deutschland GmbH
    Inventors: Pauline Fraissignes, Sabine Gratzer, Ekkehard Leberer
  • Publication number: 20040092474
    Abstract: The present invention relates to methods for identifying substances capable of influencing the activity of a target molecule affecting cellular proliferation.
    Type: Application
    Filed: July 23, 2003
    Publication date: May 13, 2004
    Applicant: Aventis Pharma GmbH
    Inventors: Sabine Gratzer, Meltsje De Hoop, Bernhard Mai
  • Publication number: 20040002115
    Abstract: The present invention relates to a method of identifying protein Constitutively Active Mutants (CAMs) and the use thereof.
    Type: Application
    Filed: January 10, 2003
    Publication date: January 1, 2004
    Inventors: Pauline Fraissignes, Sabine Gratzer, Ekkehard Leberer
  • Patent number: 6602699
    Abstract: The present invention relates to a promoter, to DNA fragments containing said promoter and to the use thereof, in particular in methods for identifying substances exhibiting an activating or inhibiting action on G protein-coupled receptors.
    Type: Grant
    Filed: November 7, 2001
    Date of Patent: August 5, 2003
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Detlef Kozian, Almut Nitsche, Pauline Fraissignes, Sabine Gratzer, Ekkehard Leberer
  • Publication number: 20030059779
    Abstract: The present invention relates to a promoter, to DNA fragments containing said promoter and to the use thereof, in particular in methods for identifying substances exhibiting an activating or inhibiting action on G protein-coupled receptors.
    Type: Application
    Filed: November 7, 2001
    Publication date: March 27, 2003
    Inventors: Detlef Kozian, Almut Nitsche, Pauline Fraissignes, Sabine Gratzer, Ekkehard Leberer